NCT01080079View on ClinicalTrials.gov

Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

June 30, 2012

Conditions
Onychomycosis
Interventions
DRUG

Terbinafine Hydrochloride

4% w/w Terbinafine Hydrochloride Gel

OTHER

Purified Water

Purified Water

Trial Locations (9)

19107

Temple University Schoool of Podiatric Medicine, Philadelphia

30078

Gwinnett Clinical Research Center, Inc, Snellville

32771

International Clinical Research, LLC, Sanford

35233

University of Alabama at Birmingham, Birmingham

37215

Tennessee Clinical Research Center, Nashville

78229

Endeavor Clinical Trials, PA, San Antonio

97210

Oregon Dermatology and Research Center, Portland

N5X 2P1

Mediprobe Research, Inc, London

L3P 1A8

Lynderm Research, Inc, Markham

Sponsors
All Listed Sponsors
lead

Nitric BioTherapeutics, Inc

INDUSTRY

NCT01080079 - Efficacy and Safety Study of Iontophoretic Application of Terbinafine Gel in Subjects With Onychomycosis | Biotech Hunter | Biotech Hunter